Photo: courtesy of Avulux
Chemistrie Avulux: A new solution for migraine and light sensitivity
August 21, 2024
Eyenavision and Avulux launched Chemistrie Avulux, a new on-demand eyeglass clip option for people living with migraine and light sensitivity.
The product combines patented, clinically proven Avulux Migraine & Light Sensitivity Lenses with the Chemistrie Lens Layering System, the patented clip-on system that attaches through the use of magnets embedded in the lenses.
“We are excited to partner with Avulux to introduce Chemistrie Avulux,” said Joe Zewe, President and Chief Executive Officer of Eyenavision. “Through the combination of our unique products, eyecare providers can now offer a seamless, on-demand solution for patients who suffer from migraine and light sensitivity. This collaboration underscores Eyenavision’s commitment to expanding patient access to lifestyle-enhancing products through our versatile and customizable Chemistrie system.”
Avalux and Eyenavision note that in addition to being a convenient option for people experiencing migraine and light sensitivity, the new Chemistrie Avulux lens also offers “all the light filtration properties that Avulux is known for: blocking up to 97 percent of harmful blue, amber and red lightwaves linked to triggering or worsening migraine attacks, while letting in soothing green light.”
Other Articles to Explore
Available now through Eyenavision’s Chemistrie Certified Lab partners, Chemistrie Avulux says it will help more eyecare providers (ECPs) expand their scope of practice and offer premium care to patients experiencing migraine.
Migraine, a complex genetic neurological disorder that often includes symptoms such as severe headaches, nausea, sensitivity to light and visual disturbances, affects nearly 48 million Americans – or as many as one in every five patients in an ECP’s practice.
For many of these patients, migraine is triggered or worsened by light. “ECPs can play a key role in caring for patients with migraine and light sensitivity,” said Dr. Charles Posternack, Chief Executive Officer of Avulux. “We are thrilled to partner with Eyenavision to help ECPs expand their scope of practice and support even more patients with the innovative new Chemistrie Avulux clips.”
